FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity – fda.gov

1. FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity  fda.gov
2. FDA approves Axogen’s nerve repair graft  Reuters
3. Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)  GlobeNewswire
4. FDA approves Axogen’s nerve repair scaffold under biologics license  Investing.com
5. Axogen, Inc. Receives FDA Approval for AVANCE® Biologics License Application to Treat Peripheral Nerve Discontinuities  Quiver Quantitative

Continue Reading